在医院环境中在药物审查中实施药物遗传学测试
Bodil Jahren Hjemås1, Katrine Bøvre1, Kathrin Bjerknes2
1Hospital Pharmacies Enterprise, South Eastern Norway, Oslo, Norway.
British journal of clinical pharmacology
|June 5, 2023
概括
药物遗传检测可以帮助入院患者的药物审查,改善药物治疗. 然而,优化工作流程至关重要,因为在住院期间,只有不到一半的患者可以获得结果.
科学领域:
- 临床药理学 临床药理学
- 遗传学 遗传学 是一个
- 内部医学 内部医学
背景情况:
- 多病症患者经常有复杂的药物治疗方案,有可能发生基因药物相互作用 (GDIs).
- 药物遗传学测试可以识别影响药物代谢和反应的遗传变异.
- 将药物遗传学纳入医院药物评价可能会优化患者护理.
研究的目的:
- 评估在住院期间进行药物遗传测试的可行性.
- 评估药物遗传学测试结果在多病患者药物评价中的实施情况.
- 确定药物遗传学见解对临床决策的影响.
主要方法:
- 包括患有多种慢性疾病的患者和常规药物与潜在的GDI.
- 采集和实验室分析血液样本用于药物遗传学测试.
- 药剂师主导的药物审查,包括可用的药物遗传学结果和可执行的GDI建议.
主要成果:
- 药物遗传试验结果可用于39.1%的患者的药物评估.
- 药剂师在42.9%的检测到的GDI中建议改变药物.
- 医院医生接受了90.5%的药剂师建议,其中常见的GDI涉及美托普罗罗尔,克洛皮多格雷尔和阿托瓦斯塔丁.
结论:
- 药物遗传学测试有可能在出院前改善住院患者的药物治疗.
- 目前的物流工作流需要优化,以增加住院期间测试结果的可用性.
- 进一步将药物遗传学纳入临床实践可以提高药物的安全性和有效性.
相关概念视频
Analysis of Population Pharmacokinetic Data
307
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
307
Pharmacovigilance
914
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
914
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
93
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
93
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
100
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
100


